About
Cardisio GmbH is a healthcare technology company based in Frankfurt am Main, Germany, founded in 2016. The company specializes in the early detection of heart disease through its innovative diagnostic technology known as Cardisiography (CSG). This non-invasive screening method is designed to be affordable, easy to use, and examiner-independent, making it accessible for early heart disease detection globally. The core product, Cardisiography, integrates traditional electrocardiography (ECG) with vectorcardiography (VCG) to enhance diagnostic accuracy, particularly for complex cardiac conditions. The process involves attaching five electrodes to the patient for a brief recording, after which an AI algorithm processes the data to generate a detailed report. This technology supports healthcare professionals, including internists and cardiologists, in making timely diagnoses, ultimately aiming to reduce cardiac-related deaths and healthcare costs. Cardisio also collaborates with international partners to distribute its technology, ensuring broad clinical adoption across various healthcare environments. The company envisions a future where reliable and non-invasive heart disease screening is accessible to everyone, improving global cardiac health outcomes.
Technologies
Keywords
Company Information
-
Employees 45
-
Founded 2016
-
Total Funding $4058870
Location
The Squaire, Frankfurt, Hesse, Germany, 60549
